Xvivo Perfusion
Xvivo Perfusion Q3’20: First impression (Redeye)

2020-10-23 08:11
Redeyes first impressions on the Q3 results. Sales came in slightly higher than we expected at SEK 42.7m vs. our SEK 40.2m. The gross margin was a tad higher than expected at 78% vs. our expectation of 76.5%. There are relatively small deviations considering the low visibility at present.

info@redeye.se (Redeye.se)
Redeye AB - Redeye.se

Xvivo Perfusion - I dag

{point.key}

Marknadsöversikt

Stockholmsbörsen, OMXS30

I dag
-
Senast
-
{point.key}

Världsindex

Index +/- % Senast
DAX - -
Hang Seng - -
Nikkei - -

Valutor

Valuta +/- % Senast
USD/SEK - -
EUR/SEK - -
GBP/SEK - -
EUR/USD - -

Räntor

Ränta +/- % Senast
5-års ränta - -
10-års ränta - -

Råvaror

Råvara +/- % Senast
Guld - -
Silver - -
Koppar - -